Agilent Technologies

Current directors and officers who also hold a role at another S&P 500 company.

• Glenn S. BoehnleinDXCM · Director
• Otis W. BrawleyINCY · Director

Latest Schedule 13D/13G filing per holder. Holders that reported falling below 5% are not shown. Index funds usually report once a year.

No 5% holder filings parsed yet for this company.

Open-market purchases and sales reported on Form 4. Grants, option exercises and tax withholding are excluded.

Every 8-K with Item 5.02 (departure, election or appointment of directors and officers). The text is the first paragraph of the item.

1. Sep 8, 2026

   (b) On September 2, 2026, Boon Hwee Koh, Chairperson of the Board of Directors (the "Board") of Agilent Technologies, Inc. (the "Company"), notified the Company of his decision to retire from the Board, effective as of September 4, 2026. Mr. Koh's decision to retire was not due to any disagreement with the Company or the Board on any matter relating to the Company's operations, policies or practices. The Company and the Board thank Mr. Koh for his valuable insights, perspective, and commitment during his 23-year service on the Board. (d) On September 4, 2026, the Board upon the recommendation of its Nominating/Corporate Governance Committee, appointed Glenn Boehnlein, to fill the vacancy created by the resignation of Mr. Koh, effective September 4, 2026 to serve as a Class III director, the class of directors that will stand for re-election at the 2027 Annual Meeting of Stockholders.

   Read the 8-K filing
2. May 27, 2026

   (b) As previously disclosed, on March 5, 2026, Rodney Gonsalves, informed the Company that he would retire from his position as the Company’s Vice President, Corporate Controller and Principal Accounting Officer, the exact date to be determined at a later time. On May 20, 2026, the Company appointed Tim Downs as the new Vice President, Chief Accounting Officer of the Company and as principal accounting officer of the Company, effective as of the first business day following the Company’s filing of the quarterly report on Form 10-Q for the quarter ended April 30, 2026 (the “Start Date”). Following the Start Date, Mr. Gonsalves will remain employed as Vice President, Finance in order to provide transitional assistance through January 2027, the exact date to be determined at a later time.

   Read the 8-K filing
3. May 4, 2026

   (b) As previously disclosed, on March 31, 2026, Bret DiMarco, Senior Vice President, Chief Legal Officer and Secretary of Agilent Technologies, Inc. (the “Company”), entered into a transition and general release agreement with the Company (the “Transition Agreement”) pursuant to which Mr. DiMarco will resign from such roles upon the earlier to occur of the start date of a new Chief Legal Officer or September 30, 2026. On May 4, 2026, the Company appointed Michael Buckner as the new Chief Legal Officer and, as a result, effective on such date, Mr. DiMarco resigned from his positions as Senior Vice President, Chief Legal Officer and Secretary of the Company. In accordance with the Transition Agreement, Mr. DiMarco will remain employed as a Special Advisor in order to provide transitional assistance through December 1, 2026.

   Read the 8-K filing
4. Apr 6, 2026

   (e) On March 31, 2026, Bret DiMarco, Senior Vice President, Chief Legal Officer and Secretary of Agilent Technologies, Inc. (the “Company”), entered into a transition and general release agreement with the Company (the “Transition Agreement”) pursuant to which Mr. DiMarco will resign from such roles upon the earlier to occur of the start date of a new Chief Legal Officer or September 30, 2026. In any event, Mr. DiMarco will continue as a Special Advisor in order to provide transitional assistance through December 1, 2026. While serving as a Special Advisor, Mr. DiMarco will be paid a base salary at the annualized rate of $350,000, will remain eligible to participate in the Company’s group health and welfare plans and will continue vesting in outstanding Company equity awards in accordance with their terms, however, Mr.

   Read the 8-K filing
5. Mar 6, 2026

   (b) On March 5, 2026, Rodney Gonsalves, informed Agilent Technologies, Inc. ("Agilent") that he would retire from his position as Agilent’s Vice President, Corporate Controller and Principal Accounting Officer in January 2027, the exact date to be determined at a later time. Mr. Gonsalves' departure is not related to any disagreement with Agilent on any matter relating to its accounting practices, financial statements, internal controls, or operations and the advance notice of his retirement allows lead time for Agilent to conduct a comprehensive search for his replacement and for Mr. Gonsalves to assist with the orderly transition of duties to his successor.

   Read the 8-K filing
6. Oct 27, 2025

   (c) On October 23, 2025, Agilent Technologies, Inc. (the "Company") appointed Adam S. Elinoff as Senior Vice President and Chief Financial Officer ("CFO") and principal financial officer of the Company effective November 17, 2025 (the "Start Date"), replacing Rodney Gonsalves, who has served as the Company's Interim CFO and Interim Principal Financial Officer since July 31, 2025. Mr. Gonsalves will continue to serve as the Company's Vice President, Corporate Controller and Principal Accounting Officer. Mr. Elinoff, age 48, has served as Vice President, Investor Relations and Treasurer of Amgen Inc. ("Amgen"), a global biotechnology company, since July 2025. Mr. Elinoff joined Amgen in 2006 and has held a series of finance, strategy, and transformation roles of increasing responsibility. From 2023 to July 2025, Mr. Elinoff served as Vice President, Finance and Treasurer.

   Read the 8-K filing
7. Aug 8, 2025

   to report the resignation of Robert W. McMahon as Senior Vice President, Chief Financial Officer of the Company and the appointment of Rodeny Gonsalves as interim Chief Financial Officer and interim Principal Financial Officer of the Company (the “Original 8-K”). The Company is filing this Form 8-K/A as an amendment to the Original 8-K to disclose details of Mr. Gonsalves’ compensation that were not determined at the time of filing the Original 8-K. The other disclosures in the Original 8-K remain the same and are not amended hereby.

   Read the 8-K filing
8. Jul 15, 2025

   (b) On July 11, 2025, Robert W. McMahon, informed Agilent Technologies, Inc. (“Agilent”) that he would resign from his position as Agilent’s Senior Vice President, Chief Financial Officer, effective July 31, 2025. Mr. McMahon’s departure is not related to any disagreement with Agilent on any matter relating to its accounting practices, financial statements, internal controls, or operations. (c) On July 14, 2025, Agilent appointed Rodney Gonsalves as interim Chief Financial Officer and interim Principal Financial Officer of Agilent, effective as of July 31, 2025. Mr. Gonsalves will continue to serve as Agilent’s Vice President, Corporate Controller and Principal Accounting Officer. Mr. Gonsalves’ biographical information can be found in Agilent’s annual report on Form 10-K for the year ended October 31, 2024 filed with the Securities and Exchange Commission on December 20, 2024.

   Read the 8-K filing
9. May 21, 2025

   (d) On May 20, 2025, the Board of Directors (the “Board”) of Agilent Technologies, Inc. (the “Company”), upon the recommendation of its Nominating/Corporate Governance Committee, increased the size of the Board from 10 to 12 members and appointed Pascal Soriot and Judy Gawlik Brown, to fill the vacancies so created, both effective May 20, 2025. Mr. Soriot was appointed to serve in the class of directors that will stand for re-election at the 2028 Annual Meeting of Stockholders. Ms. Brown was appointed to serve in the class of directors that will stand for re-election at the 2026 Annual Meeting of Stockholders. Mr. Soriot, age 65, has served as an Executive Director on the Board of Directors and Chief Executive Officer of AstraZeneca Plc since October 2012. Prior to joining AstraZeneca, Mr.

   Read the 8-K filing
10. May 2, 2025

    On April 28, 2025, Henrick Ancher-Jensen, Senior Vice President, Agilent President, Order Fulfillment and Supply Chain of Agilent Technologies, Inc. (the “Company”), notified the Company of his decision to resign from his position effective as of June 1, 2025, to pursue another opportunity.

    Read the 8-K filing
11. Apr 2, 2025

    On March 27, 2025, Heidi Kunz, a member of the Board of Directors (the “Board”) of Agilent Technologies, Inc. (the “Company”), a member of the Compensation Committee of the Board (the “Compensation Committee”), and a member of the Nominating/Corporate Governance Committee of the Board (together with the Compensation Committee, the “Committees”), notified the Chairman of the Board of her decision to resign from the Board and the Committees, effective as of May 21, 2025. Ms. Kunz’s decision to resign was not due to any disagreement with the Company or the Board on any matter relating to the Company’s operations, policies or practices. The Company and the Board thank Ms. Kunz for her valuable insights, perspective, and commitment during her service on the Board.

    Read the 8-K filing
12. May 24, 2024

    to report the retirement of Michael R. McMullen as President and CEO (“ CEO ”) of the Company and as a member of the Company’s Board of Directors (“ Board ”) and the appointment of Padraig McDonnell as the CEO of the Company and as a member of the Company’s Board. The Company is filing this Form 8-K/A as an amendment (Amendment No. 1) to the aforementioned Form 8-K to disclose details of Mr. McDonnell’s compensation that was expected to be approved in connection with such appointments, but was not determined at the time of the initial filing.

    Read the 8-K filing
13. May 24, 2024

    Election of Directors; Appointment of Certain Officers. On May 22, 2024, Hans E. Bishop notified the board of directors (the “ Board ”) of Agilent Technologies, Inc. (the “ Company ”) of his intention to step down as a member of the Company’s Board, effective as of May 23, 2024. Mr. Bishop is a member of the Compensation Committee and Nominating/Corporate Governance Committee of the Board. Mr. Bishop has served as a member of the Board since 2017. Mr. Bishop’s departure is not the result of any disagreement with the Company regarding its operations, policies or practices. In connection with Mr. Bishop’s departure, the size of the Board has been reduced from eleven (11) to ten (10) directors, effective as of May 23, 2024. The Company issued a press release on May 23, 2024 announcing Mr. Bishop’s departure from the Company’s Board.

    Read the 8-K filing
14. May 1, 2024

    Election of Directors; Appointment of Certain Officers. (b) On February 21, 2024, Agilent Technologies, Inc. (the “ Company ”) previously announced that Michael McMullen would retire as President and Chief Executive Officer (“ CEO ”) of the Company and as a member of the Company’s Board of Directors (“ Board ”) effective May 1, 2024. Mr. McMullen will continue his employment with the Company as a senior adviser from May 1, 2024 through October 31, 2024, the end of the Company’s fiscal year. (c) On May 1, 2024, Mr. McMullen retired as President and CEO of the Company and as a member of the Company’s Board. The Board appointed Padraig McDonnell as CEO of the Company and as a member of the Company’s Board. In connection with Mr. McDonnell’s appointment as CEO, the Board will review and potentially approve certain changes to Mr. McDonnell’s compensation package on May 21, 2024.

    Read the 8-K filing
15. Feb 21, 2024

    (b) On February 20, 2024, Michael McMullen, President and Chief Executive Officer (“CEO”) of Agilent Technologies, Inc. (the “Company” or “Agilent”), notified the Company that he will retire as President and CEO of the Company and as a member of the Company’s Board of Directors (“Board”) on May 1, 2024. From May 1, 2024 through October 31, 2024, Mr. McMullen is expected to continue his employment with the Company as a senior advisor. (c) On February 20, 2024, the Board appointed Padraig McDonnell, age 52 and a Senior Vice President of the Company, as Chief Operating Officer (“COO”) and CEO-elect. Upon Mr. McMullen’s retirement, the Board intends to appoint Mr. McDonnell as CEO. The Company also intends to nominate Mr. McDonnell to the Board upon Mr. McMullen’s retirement. Since joining Agilent in 1998, Mr.

    Read the 8-K filing

Proxy statements (DEF 14A): 2026 · 2025 · 2024 · 2023 · 2022 · 2021

From the company's 10-K XBRL data (SEC companyfacts).

People who stopped filing as an insider of this company. “Last filing” is the last Form 3/4/5, an upper bound on when they left.